246 related articles for article (PubMed ID: 14968476)
1. [New molecular features of cholestatic diseases of the liver].
Méndez-Sánchez N; Chavez-Tapia NC; Uribe M
Rev Invest Clin; 2003; 55(5):546-56. PubMed ID: 14968476
[TBL] [Abstract][Full Text] [Related]
2. [New molecular aspects of cholestatic liver diseases].
Trauner M; Fickert P; Stauber RE
Z Gastroenterol; 1999 Jul; 37(7):639-47. PubMed ID: 10458013
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular bile salt transport: lessons from cholestasis.
Trauner M; Fickert P; Stauber RE
Can J Gastroenterol; 2000 Nov; 14 Suppl D():99D-104D. PubMed ID: 11110621
[TBL] [Abstract][Full Text] [Related]
4. The expression levels of plasma membrane transporters in the cholestatic liver of patients undergoing biliary drainage and their association with the impairment of biliary secretory function.
Shoda J; Kano M; Oda K; Kamiya J; Nimura Y; Suzuki H; Sugiyama Y; Miyazaki H; Todoroki T; Stengelin S; Kramer W; Matsuzaki Y; Tanaka N
Am J Gastroenterol; 2001 Dec; 96(12):3368-78. PubMed ID: 11774951
[TBL] [Abstract][Full Text] [Related]
5. Molecular alterations of canalicular transport systems in experimental models of cholestasis: possible functional correlations.
Trauner M
Yale J Biol Med; 1997; 70(4):365-78. PubMed ID: 9626757
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiology of cholestasis with special reference to primary biliary cirrhosis.
Jansen PL
Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):571-83. PubMed ID: 10976015
[TBL] [Abstract][Full Text] [Related]
7. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
Trauner M; Wagner M; Fickert P; Zollner G
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
[TBL] [Abstract][Full Text] [Related]
8. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations of bile salt transporters as predisposing factors for drug-induced cholestasis, intrahepatic cholestasis of pregnancy and therapeutic response of viral hepatitis.
Stieger B; Geier A
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):411-25. PubMed ID: 21320040
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of hepatocellular transporters.
Pauli-Magnus C; Meier PJ
Pharmacogenetics; 2003 Apr; 13(4):189-98. PubMed ID: 12668915
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of cholestasis.
Zollner G; Trauner M
Wien Med Wochenschr; 2006 Jul; 156(13-14):380-5. PubMed ID: 16937039
[TBL] [Abstract][Full Text] [Related]
12. [Intrahepatic cholestasis].
Adachi Y; Kamisako T
Nihon Rinsho; 1996 Mar; 54(3):788-93. PubMed ID: 8904238
[TBL] [Abstract][Full Text] [Related]
13. A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
Luo J; Ko B; Elliott M; Zhou M; Lindhout DA; Phung V; To C; Learned RM; Tian H; DePaoli AM; Ling L
Sci Transl Med; 2014 Jul; 6(247):247ra100. PubMed ID: 25080475
[TBL] [Abstract][Full Text] [Related]
14. Role of farnesoid X receptor in cholestasis.
Yuan ZQ; Li KW
J Dig Dis; 2016 Aug; 17(8):501-509. PubMed ID: 27383832
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasis.
Wagner M; Trauner M
Ann Hepatol; 2005; 4(2):77-99. PubMed ID: 16010241
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular transporters and cholestasis.
Pauli-Magnus C; Meier PJ
J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S103-10. PubMed ID: 15758645
[TBL] [Abstract][Full Text] [Related]
17. Hepatobiliary transporters and drug-induced cholestasis.
Pauli-Magnus C; Meier PJ
Hepatology; 2006 Oct; 44(4):778-87. PubMed ID: 17006912
[TBL] [Abstract][Full Text] [Related]
18. [The descending pathophysiology model of cholestatic liver disease].
Cai XB; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):321-324. PubMed ID: 31177654
[TBL] [Abstract][Full Text] [Related]
19. Bile acid metabolism and FXR-mediated effects in human cholestatic liver disorders.
Molinaro A; Marschall HU
Biochem Soc Trans; 2022 Feb; 50(1):361-373. PubMed ID: 35191955
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of bile formation and cholestatic diseases].
Poupon R
Bull Acad Natl Med; 2003; 187(7):1261-74; discussion 1274-6. PubMed ID: 15146603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]